Daiwa Securities Group
CRBU icon

Daiwa Securities Group’s Caribou Biosciences CRBU Stock Holding History

Daiwa Securities Group’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-176
Closed – – 1292
2024
Q3 		$0 Hold
176
– – ﹤0.01% 1292
2024
Q2 		$0 Hold
176
– – ﹤0.01% 1330
2024
Q1 		$1K Hold
176
– – ﹤0.01% 1292
2023
Q4 		$1K Hold
176
– – ﹤0.01% 1293
2023
Q3 		$1K Hold
176
– – ﹤0.01% 1244
2023
Q2 		$1K Hold
176
– – ﹤0.01% 1266
2023
Q1 		$1K Hold
176
– – ﹤0.01% 1247
2022
Q4 		$1K Hold
176
– – ﹤0.01% 1265
2022
Q3 		$2K Hold
176
– – ﹤0.01% 1221
2022
Q2 		$1K Hold
176
– – ﹤0.01% 1283
2022
Q1 		$2K Hold
176
– – ﹤0.01% 1245
2021
Q4 		$3K Buy
+176
New +$3.42K ﹤0.01% 1237

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Daiwa Securities Group's CRBU Position: Q4 2024 in Review

Daiwa Securities Group sold out of Caribou Biosciences (CRBU) in Q4 2024, closing a stake of 176 shares.

Daiwa Securities Group first reported a position in CRBU in Q4 2021 and held it in 12 quarters. The position peaked at $3K in Q4 2021. 133 funds tracked by Wall St. Rank hold CRBU as of Q4 2024.

  • Daiwa Securities Group reported no remaining Caribou Biosciences position as of Q4 2024 after selling out during the quarter.
  • Daiwa Securities Group sold 176 Caribou Biosciences shares in Q4 2024.
  • Daiwa Securities Group first reported a position in Caribou Biosciences in Q4 2021 and held it in 12 quarters.
  • Daiwa Securities Group's Caribou Biosciences position peaked at $3K in Q4 2021.
  • 133 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2024.

Based on Daiwa Securities Group's 13F filing for Q4 2024, filed 7 Feb 2025.